121 related articles for article (PubMed ID: 26235178)
1. Targeting aggressive cancers with an artificial sweetener: could saccharin be a lead compound in anticancer therapy?
Mahon BP; Okoh CO; McKenna R
Future Oncol; 2015; 11(15):2117-9. PubMed ID: 26235178
[No Abstract] [Full Text] [Related]
2. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
Ozensoy Guler O; Arslan O; Kockar F
Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
[TBL] [Abstract][Full Text] [Related]
3. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.
Panelli MC; Wang E; Marincola FM
Clin Cancer Res; 2005 May; 11(10):3601-3. PubMed ID: 15897553
[No Abstract] [Full Text] [Related]
4. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX: regulation and role in cancer.
Benej M; Pastorekova S; Pastorek J
Subcell Biochem; 2014; 75():199-219. PubMed ID: 24146381
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
Supuran CT; Winum JY
Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
[TBL] [Abstract][Full Text] [Related]
8. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs.
Thiry A; Supuran CT; Masereel B; Dogné JM
J Med Chem; 2008 Jun; 51(11):3051-6. PubMed ID: 18348513
[No Abstract] [Full Text] [Related]
9. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.
McDonald PC; Winum JY; Supuran CT; Dedhar S
Oncotarget; 2012 Jan; 3(1):84-97. PubMed ID: 22289741
[TBL] [Abstract][Full Text] [Related]
11. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792
[TBL] [Abstract][Full Text] [Related]
12. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
Carradori S
Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
[TBL] [Abstract][Full Text] [Related]
13. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT
J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
Pastorek J; Pastorekova S
Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.
McDonald PC; Dedhar S
Subcell Biochem; 2014; 75():255-69. PubMed ID: 24146383
[TBL] [Abstract][Full Text] [Related]
18. The role of carbonic anhydrase IX in hypoxia control in OSCC.
Pérez-Sayáns M; Supuran CT; Pastorekova S; Suárez-Peñaranda JM; Pilar GD; Barros-Angueira F; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2013 Jan; 42(1):1-8. PubMed ID: 22417164
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
Ditte P; Dequiedt F; Svastova E; Hulikova A; Ohradanova-Repic A; Zatovicova M; Csaderova L; Kopacek J; Supuran CT; Pastorekova S; Pastorek J
Cancer Res; 2011 Dec; 71(24):7558-67. PubMed ID: 22037869
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
